A detailed history of Waldron Private Wealth LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Waldron Private Wealth LLC holds 9,902 shares of GILD stock, worth $872,168. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,902
Previous 9,218 7.42%
Holding current value
$872,168
Previous $632,000 31.17%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$66.59 - $83.99 $45,547 - $57,449
684 Added 7.42%
9,902 $829,000
Q2 2024

Jul 31, 2024

SELL
$63.15 - $72.88 $17,745 - $20,479
-281 Reduced 2.96%
9,218 $632,000
Q1 2024

May 09, 2024

SELL
$71.58 - $87.29 $59,339 - $72,363
-829 Reduced 8.03%
9,499 $695,000
Q4 2023

Aug 29, 2024

BUY
$73.27 - $83.09 $293 - $332
4 Added 0.04%
10,328 $836,000
Q4 2023

Jan 30, 2024

BUY
$73.27 - $83.09 $293 - $332
4 Added 0.04%
10,328 $836,000
Q3 2023

Aug 29, 2024

SELL
$73.94 - $80.67 $147 - $161
-2 Reduced 0.02%
10,324 $773,000
Q3 2023

Oct 26, 2023

SELL
$73.94 - $80.67 $147 - $161
-2 Reduced 0.02%
10,324 $773,000
Q2 2023

Aug 29, 2024

SELL
$76.01 - $86.7 $29,111 - $33,206
-383 Reduced 3.58%
10,326 $795,000
Q2 2023

Aug 07, 2023

SELL
$76.01 - $86.7 $29,111 - $33,206
-383 Reduced 3.58%
10,326 $795,000
Q1 2023

Aug 29, 2024

BUY
$77.31 - $88.08 $115,269 - $131,327
1,491 Added 16.17%
10,709 $888,000
Q1 2023

May 02, 2023

BUY
$77.31 - $88.08 $18,631 - $21,227
241 Added 2.3%
10,709 $888,000
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $62,040 - $70,866
1,042 Added 11.05%
10,468 $645,000
Q2 2022

Aug 03, 2022

BUY
$57.72 - $65.01 $27,532 - $31,009
477 Added 5.33%
9,426 $582,000
Q1 2022

May 04, 2022

BUY
$57.92 - $72.58 $13,495 - $16,911
233 Added 2.67%
8,949 $532,000
Q4 2021

Feb 02, 2022

SELL
$64.88 - $73.64 $6,747 - $7,658
-104 Reduced 1.18%
8,716 $632,000
Q3 2021

Nov 02, 2021

BUY
$67.69 - $73.03 $222,632 - $240,195
3,289 Added 59.46%
8,820 $616,000
Q2 2021

Aug 06, 2021

SELL
$63.47 - $69.35 $253 - $277
-4 Reduced 0.07%
5,531 $380,000
Q1 2021

May 11, 2021

SELL
$60.0 - $68.46 $1,260 - $1,437
-21 Reduced 0.38%
5,535 $357,000
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $17,334 - $19,752
-306 Reduced 5.22%
5,556 $323,000
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $55,641 - $69,959
896 Added 18.04%
5,862 $370,000
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $38,267 - $44,436
529 Added 11.92%
4,966 $382,000
Q1 2020

May 05, 2020

BUY
$62.63 - $80.22 $17,599 - $22,541
281 Added 6.76%
4,437 $331,000
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $3,882 - $4,270
-63 Reduced 1.49%
4,156 $270,000
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $2,000 - $2,208
-32 Reduced 0.75%
4,219 $267,000
Q2 2019

Jul 31, 2019

SELL
$61.87 - $69.38 $96,950 - $108,718
-1,567 Reduced 26.93%
4,251 $287,000
Q1 2019

May 01, 2019

SELL
$62.53 - $70.05 $14,694 - $16,461
-235 Reduced 3.88%
5,818 $378,000
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $101,767 - $132,799
1,681 Added 38.45%
6,053 $378,000
Q3 2018

Nov 20, 2018

BUY
$71.28 - $78.92 $11,547 - $12,785
162 Added 3.85%
4,372 $337,000
Q2 2018

Aug 09, 2018

SELL
$64.88 - $75.68 $33,088 - $38,596
-510 Reduced 10.81%
4,210 $298,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,720
4,720 $334,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.